Published in J Inflamm Res on March 27, 2013
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax (2014) 1.76
Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol (2013) 0.98
Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci (2013) 0.80
Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis. PLoS One (2016) 0.79
Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis. Fibrogenesis Tissue Repair (2015) 0.78
Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased β-catenin inhibition and increased Wnt5a/b interaction. Physiol Rep (2016) 0.75
Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Idiopathic pulmonary fibrosis and a role for autoimmunity. Immunol Cell Biol (2017) 0.75
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med (1976) 4.85
Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis. Thorax (1967) 4.43
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
Glucocorticoid resistance in inflammatory diseases. Lancet (2009) 3.57
Integrating mechanisms of pulmonary fibrosis. J Exp Med (2011) 3.57
Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum (1999) 2.22
Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2002) 2.08
Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun (2004) 1.98
Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol (2002) 1.72
Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest (2005) 1.49
Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol (2007) 1.42
Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 1.37
Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol (2006) 1.35
Idiopathic pulmonary fibrosis: new insights into pathogenesis. Clin Chest Med (2004) 1.31
Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol (2007) 1.28
Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med (2011) 1.21
Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration (2006) 1.08
Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes. Arthritis Rheum (2009) 1.07
Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum (2006) 1.04
CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Respir Res (2005) 1.04
Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies. Histopathology (2008) 0.89
Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome? Thorax (1990) 0.89
Pathology of the vulnerable plaque. J Am Coll Cardiol (2006) 7.79
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol (2015) 5.83
Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med (2003) 5.43
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 4.29
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation (2008) 2.64
Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol (2002) 2.53
Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol (2006) 2.51
From the archives of the AFIP: Localized fibrous tumor of the pleura. Radiographics (2003) 2.38
Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest (2003) 2.16
Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med (2002) 2.11
Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol (2003) 2.08
Iatrogenic cardiac papillary fibroelastoma: a study of 12 cases (1990 to 2000). Hum Pathol (2002) 2.06
Histopathology of carotid atherosclerotic disease. Neurosurgery (2006) 2.05
Morphological predictors of restenosis after coronary stenting in humans. Circulation (2002) 2.03
Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging (2008) 2.01
Cardiac myxoma: imaging features in 83 patients. Radiographics (2002) 1.92
Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls. J Thorac Cardiovasc Surg (2011) 1.79
Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol (2007) 1.78
Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation (2003) 1.76
Pathogenesis of unexplained drowning: new insights from a molecular autopsy. Mayo Clin Proc (2005) 1.76
Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol (2003) 1.74
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol (2005) 1.69
Idiopathic interstitial pneumonias: CT features. Radiology (2005) 1.61
From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics (2013) 1.61
Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Mod Pathol (2007) 1.61
From the radiologic pathology archives: cardiac lymphoma: radiologic-pathologic correlation. Radiographics (2012) 1.55
Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention (2009) 1.53
HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46
From the archives of the AFIP: Pleuropulmonary synovial sarcoma. Radiographics (2006) 1.45
Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol (2007) 1.42
Pathology of the unstable plaque. Prog Cardiovasc Dis (2002) 1.41
Do "intimal" sarcomas of the heart exist? Am J Surg Pathol (2014) 1.39
Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts. Am J Respir Cell Mol Biol (2003) 1.38
Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 1.37
Extracellular matrix changes in stented human coronary arteries. Circulation (2004) 1.32
From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. Radiographics (2004) 1.32
Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol (2002) 1.31
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol (2006) 1.31
Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol (2007) 1.28
Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process. Diagn Pathol (2008) 1.28
Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med (2003) 1.28
HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27
Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol (2002) 1.23
Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenesis Tissue Repair (2011) 1.23
Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers. Diagn Pathol (2007) 1.23
Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases. Am J Surg Pathol (2010) 1.21
Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol (2002) 1.21
Regulation of inflammation by interleukin-4: a review of "alternatives". J Leukoc Biol (2012) 1.20
Sarcomatoid carcinoma of the lung: histologic criteria and common lesions in the differential diagnosis. Arch Pathol Lab Med (2010) 1.19
Sclerosing hemangioma of the lung. Arch Pathol Lab Med (2009) 1.19
Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J Immunol (2012) 1.15
From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics (2007) 1.14
Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. J Immunol (2008) 1.13
Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts. J Immunol (2008) 1.11
Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum (2003) 1.10
Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res (2006) 1.07
Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes. Arthritis Rheum (2009) 1.07
Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol (2011) 1.06
Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1. Arterioscler Thromb Vasc Biol (2006) 1.05
Free cholesterol in atherosclerotic plaques: where does it come from? Curr Opin Lipidol (2007) 1.04
Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum (2006) 1.04
From the archives of the AFIP: pulmonary alveolar proteinosis. Radiographics (2008) 1.03
CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity. J Cell Physiol (2006) 1.02
Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques. BMC Cardiovasc Disord (2009) 1.01
Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J Immunol (2002) 1.00
Intimal sarcomas of the aorta and iliofemoral arteries: a clinicopathological study of 26 cases. Pathology (2014) 1.00
Endobronchial metallic stent placement for airway complications after lung transplantation: longitudinal results. Ann Thorac Surg (2002) 0.99
Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart Lung (2004) 0.99
Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol (2013) 0.98
PKCalpha mediates CCL18-stimulated collagen production in pulmonary fibroblasts. Am J Respir Cell Mol Biol (2006) 0.98
Discrepancies between clinical and autopsy diagnoses: a comparison of university, community, and private autopsy practices. Am J Clin Pathol (2008) 0.98
TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J Clin Invest (2014) 0.98
Granulomatous reaction to pneumocystis jirovecii: clinicopathologic review of 20 cases. Am J Surg Pathol (2010) 0.97
From the archives of the AFIP: lymphangioleiomyomatosis: radiologic-pathologic correlation. Radiographics (2005) 0.97
Virtual autopsy: two- and three-dimensional multidetector CT findings in drowning with autopsy comparison. Radiology (2007) 0.96
Occult primary parotid gland acinic cell adenocarcinoma presenting with extensive lung metastasis. Arch Pathol Lab Med (2007) 0.95
Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol (2006) 0.94
Multiple aneurysms of aortocoronary saphenous vein grafts with fatal rupture. Arq Bras Cardiol (2007) 0.93
Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis. Expert Rev Respir Med (2015) 0.92
NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling. J Biol Chem (2012) 0.92
Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammation. Am J Pathol (2012) 0.89
Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol (2007) 0.89
Alternatively spliced variants of interleukin-4 promote inflammation differentially. J Leukoc Biol (2011) 0.89
Lung tumors with neuroendocrine morphology: essential radiologic and pathologic features. Arch Pathol Lab Med (2008) 0.88